NCT07175506View on ClinicalTrials.gov

Study of CM559 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Subjects
Interventions
DRUG

Placebo

Placebo injection administered IV, once.

BIOLOGICAL

CM559

CM559 injection administered IV, once.

Trial Locations (1)

Unknown

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT07175506 - Study of CM559 in Healthy Subjects | Biotech Hunter | Biotech Hunter